scholarly article | Q13442814 |
P50 | author | Itzia Jimenez-Ferrer | Q57412386 |
Maria Swanberg | Q58034743 | ||
P2093 | author name string | Michael Jewett | |
P2860 | cites work | Dopamine neuron systems in the brain: an update | Q22251429 |
Oxidative stress and Parkinson's disease | Q26798897 | ||
Genetics of Parkinson's disease | Q26827825 | ||
Immunohistological analysis of glutathione transferase A4 distribution in several human tissues using a specific polyclonal antibody | Q28207820 | ||
Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse | Q28242302 | ||
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 | ||
Parkin regulates Eg5 expression by Hsp70 ubiquitination-dependent inactivation of c-Jun NH2-terminal kinase | Q28296466 | ||
Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons | Q28580736 | ||
The efficiency of systematic sampling in stereology--reconsidered. | Q52213559 | ||
Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS | Q63433239 | ||
Maintenance of neuronal glutathione by glial cells | Q72576519 | ||
Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat | Q73351171 | ||
Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons | Q80488890 | ||
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance | Q29616511 | ||
Fine mapping of gene regions regulating neurodegeneration | Q33467388 | ||
Disruption of the mGsta4 gene increases life span of C57BL mice | Q33552125 | ||
Neurotoxic in vivo models of Parkinson's disease recent advances. | Q33708283 | ||
Glutathione, oxidative stress and neurodegeneration | Q33994473 | ||
Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway | Q34133059 | ||
Genetic dissection of strain dependent paraquat-induced neurodegeneration in the substantia nigra pars compacta | Q34145821 | ||
The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors | Q34165134 | ||
Putting a spin on the dorsal-ventral divide of the striatum. | Q34335471 | ||
The clinical symptoms of Parkinson's disease | Q34533843 | ||
Genetic and environmental factors in the cause of Parkinson's disease | Q35094884 | ||
4-hydroxynonenal and neurodegenerative diseases | Q35189565 | ||
A guide to neurotoxic animal models of Parkinson's disease | Q35603488 | ||
Neurodegeneration or neuroprotection: the pivotal role of astrocytes | Q35707212 | ||
Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease | Q36102644 | ||
Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease | Q36109874 | ||
Effects of Local Heart Irradiation in a Glutathione S-Transferase Alpha 4-Null Mouse Model | Q36395493 | ||
Naturally occurring variation in the Glutathione-S-Transferase 4 gene determines neurodegeneration after traumatic brain injury | Q36562655 | ||
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease | Q36622356 | ||
Gsta4 Null Mouse Embryonic Fibroblasts Exhibit Enhanced Sensitivity to Oxidants: Role of 4-Hydroxynonenal in Oxidant Toxicity | Q37394472 | ||
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease | Q37671552 | ||
Parkinson's disease: evidence for environmental risk factors | Q38055457 | ||
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription | Q39796090 | ||
The genetic basis of complex human behaviors | Q40765482 | ||
Mechanism of 6-hydroxydopamine neurotoxicity. | Q41446809 | ||
Antioxidant defense of the brain: a role for astrocytes | Q41683285 | ||
(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease | Q42541023 | ||
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease | Q42908536 | ||
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans | Q43868792 | ||
Glutathione S-transferase isoenzymatic response to aging in rat cerebral cortex and cerebellum. | Q44324479 | ||
Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats | Q46591178 | ||
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. | Q48170542 | ||
Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration. | Q48358396 | ||
Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice | Q48385648 | ||
Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. | Q48408339 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P921 | main subject | dopamine | Q170304 |
P577 | publication date | 2017-06-26 | |
P1433 | published in | Brain Sciences | Q27724596 |
P1476 | title | Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson's Disease | |
P478 | volume | 7 |
Q55085565 | Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson's Disease. | cites work | P2860 |
Search more.